SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Enzo Biochem
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve who wrote (73)1/31/1997 12:02:00 PM
From: Steve   of 83
 
Any comments on this release?????
What connection does this firm have to ENZO and is this a significant upgrade??



Friday January 31 10:09 AM EDT

M.H. Meyerson & Co., Inc. Rates Enzo Biochem, Inc.
'Strong Buy'

JERSEY CITY, N.J., Jan. 31 /PRNewswire/ -- M.H. Meyerson & Co., Inc. (Nasdaq-NNM:
MHMY) announced a Research Report available on Enzo Biochem Inc prepared by Aaron
Lehmann, Senior Investment Analyst of M.H. Meyerson & Co., Inc., 525 Washington Blvd.,
Jersey City, New Jersey 07310. SOURCE M.H. Meyerson & Co., Inc.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News